Abstract
NF-κB-inducing kinase (NIK) is a central component in the non-canonical NF-κB signaling pathway. Excessive NIK activity is implicated in various disorders, such as autoimmune conditions and cancers. Here, we report the first crystal structure of truncated human NIK in complex with adenosine 5'-O-(thiotriphosphate) at a resolution of 2.5 Å. This truncated protein is a catalytically active construct, including an N-terminal extension of 60 residues prior to the kinase domain, the kinase domain, and 20 residues afterward. The structure reveals that the NIK kinase domain assumes an active conformation in the absence of any phosphorylation. Analysis of the structure uncovers a unique role for the N-terminal extension sequence, which stabilizes helix αC in the active orientation and keeps the kinase domain in the catalytically competent conformation. Our findings shed light on the long-standing debate over whether NIK is a constitutively active kinase. They also provide a molecular basis for the recent observation of gain-of-function activity for an N-terminal deletion mutant (ΔN324) of NIK, leading to constitutive non-canonical NF-κB signaling with enhanced B-cell adhesion and apoptosis resistance.
Highlights
NF-B-inducing kinase (NIK) is a central component in the non-canonical NF-B pathway, and its activity is associated with various diseases
The structure reveals that the NIK kinase domain assumes an active conformation in the absence of any phosphorylation
Constructs with an N terminus starting from the kinase domain or with a C terminus ending at the kinase domain failed to produce catalytically active proteins
Summary
NIK is a central component in the non-canonical NF-B pathway, and its activity is associated with various diseases. There are 947 amino acids in the human NIK sequence, which contains at least four identified domains, including an N-terminal TRAF3binding domain (approximately residues 30 –120), a negative regulatory domain (approximately residues 121–318), a central serine/threonine kinase domain (approximately residues 390 – 660), and a C-terminal non-catalytic region that is required for. Such a catalytically competent conformation is maintained by an N-terminal extension prior to the kinase domain rather than through a phosphorylation event
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.